One thing Merck does not have is its own version of the hot new weight-loss medicines that have made Eli Lilly and Novo ...

Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...

Columbus Blue Jackets standout Johnny Gaudreau and his younger brother have died after being struck by a vehicle while riding bikes in New Jersey, the team and National Hockey League (NHL ...

Merck (NYSE: MRK) is a top pharmaceutical company ... One of the keys to replacing the lost revenue will be new drugs, including Winrevair, a treatment for pulmonary arterial hypertension.

Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts. Benzinga is an innovative financial news outlet that has become the first choice for brokerages given ...

Merck lowered 2024 EPS guidance down to $7.94 to $8.03, from its previous guidance of $8.53 to $8.65. The new guidance reflects the negative impact of a one-time charge of $1.3 billion or 51 cents ...

In the wake of Merck’s latest setback, the search for a viable PD-1/L1 inhibitor in stage 1 or 2 unresected NSCLC is still ongoing for at least one other company. AstraZeneca is conducting the ...

We recently compiled a list of the 15 Best European AI Stocks According to Morgan Stanley. In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF) stands against the other ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in ... We also discuss the latest news in the life sciences, including Moderna ...

RAHWAY, N.J., September 04, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data for four approved medicines and six pipeline candidates in ...